Literature DB >> 16629618

Targeting Rho to stimulate repair after spinal cord injury.

Lisa McKerracher1, Haruhisa Higuchi.   

Abstract

Rho is an important signaling target to promote repair following spinal cord injury (SCI). Myelin-derived inhibitory proteins, as well as other classes of known growth inhibitory proteins, block regeneration by signaling activation of Rho. Here, we review the molecular mechanisms of Rho activation after SCI and explain known Rho signaling antagonists. We review the data on use of Rho antagonists to promote axon regeneration, neuroprotection, and functional recovery after SCI. We report on efforts to translate the nonclincal studies on rodents to clinical trials in patients with acute SCI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629618     DOI: 10.1089/neu.2006.23.309

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  47 in total

1.  Sialidase enhances recovery from spinal cord contusion injury.

Authors:  Andrea Mountney; Matthew R Zahner; Ileana Lorenzini; Martin Oudega; Lawrence P Schramm; Ronald L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system.

Authors:  Ping Yang; Hui-zhong Wen; Jin-hai Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-12       Impact factor: 6.150

3.  RhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment.

Authors:  Aurora Maria Fontainhas; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

Review 4.  Neuronal polarity.

Authors:  Sabina Tahirovic; Frank Bradke
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

5.  The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury.

Authors:  Yosuke Ohtake; Dongsun Park; P M Abdul-Muneer; Hui Li; Bin Xu; Kartavya Sharma; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Biomaterials       Date:  2014-03-12       Impact factor: 12.479

6.  A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach.

Authors:  Albert Ries; Jeffrey L Goldberg; Barbara Grimpe
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

Review 7.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

8.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

9.  SCY1-Like 1-Binding Protein 1 (SCYL1BP1) Suppressed Sciatic Nerve Regeneration by Enhancing the RhoA Pathway.

Authors:  Weidong Zhang; Yonghua Liu; Xudong Zhu; Yi Cao; Yang Liu; Xingxing Mao; Huiguang Yang; Zhengming Zhou; Youhua Wang; Aiguo Shen
Journal:  Mol Neurobiol       Date:  2015-11-16       Impact factor: 5.590

10.  Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion.

Authors:  Dongsheng Wu; Ping Yang; Xinyu Zhang; Juan Luo; Mohammed E Haque; John Yeh; Peter M Richardson; Yi Zhang; Xuenong Bo
Journal:  Mol Ther       Date:  2009-07-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.